Franz-Josef Obermair

Franz has over 15 years of academic experience in molecular immunology and cell biology and is the General Manger of Tepthera Ltd., a subsidiary of Repertoire Immune Medicine. He is one of the founders of Tepthera Ltd., a spin-off from the ETH Zurich. He co-invented and developed platform technologies to identify T cell reactivities with the vision to bring immune medicine to a new level of precision. He earned his PhD at the ETH Zurich.